As vaccine-makers rush to prove efficacy in their tweaked COVID-19 boosters targeting omicron and regulators mark calendars for a rollout this fall, some experts say the process needs to be rushed, according to The New York Times.
Read the full post on Becker's Hospital Review - Healthcare News
